BioDelivery Sciences Inte...

NASDAQ: BDSI · Real-Time Price · USD
5.59
-0.00 (-0.09%)
At close: Mar 22, 2022, 9:00 PM

BioDelivery Sciences International Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
166.71M 165.72M 164.07M 159.21M
Cost of Revenue
23.37M 24.76M 23.77M 24.93M
Gross Profit
143.33M 140.95M 140.29M 134.29M
Operating Income
37.13M 40.53M 42.87M 34.43M
Interest Income
n/a n/a n/a n/a
Pretax Income
29.62M 32.54M 34.86M 26.73M
Net Income
84.86M 31.17M 33.88M 25.98M
Selling & General & Admin
106.21M 100.43M 97.42M 99.85M
Research & Development
n/a n/a n/a n/a
Other Expenses
-6K -10K -12K -3K
Operating Expenses
106.21M 100.43M 97.42M 99.85M
Interest Expense
7.5M 7.98M 8M 7.7M
Selling & Marketing Expenses
n/a -5.32M -5.32M -5.32M
Cost & Expenses
129.58M 125.19M 121.19M 124.78M
Income Tax Expense
-55.24M 1.37M 978K 752K
Shares Outstanding (Basic)
99.32M 98.7M 98.79M 100.99M
Shares Outstanding (Diluted)
103.29M 102.43M 102.51M 105.4M
EPS (Basic)
0.85 0.31 0.33 0.25
EPS (Diluted)
0.82 0.31 0.33 0.25
EBITDA
40.95M 44.09M 48.19M 40.15M
EBIT
37.12M 40.52M 42.86M 34.43M
Depreciation & Amortization
7.42M 7.15M 7.07M 7.46M